Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2858 results

Sort By:

A Study of AND017 in Cancer Related Anemic Patients Receiving Chemotherapy

Study ID: NCT06075030
Start Date: 2027-12
End Date: 2028-05
Study Type

Interventional

Study Phase

Phase2

No. of Participants

36

Intervention / Treatment

AND017

Sponsor

Kind Pharmaceuticals LLC

Source: clinicaltrials.gov

Share:
Add to list

Berbevis Dose-finding Study in Subjects With Impaired Fasting Glucose

Study ID: NCT06955234
Start Date: 2026-06-15
End Date: 2026-09-15
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

90

Intervention / Treatment

Berbevis supplement

Sponsor

Pavia Personal Services Company

Source: clinicaltrials.gov

Share:
Add to list

NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy

Study ID: NCT07227909
Start Date: 2026-05-04
End Date: 2031-01-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

83

Intervention / Treatment

Psilocybin (drug)

Psilocybin (drug)

Standard of Care (SOC)

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Multi-Parametric MRI for Renal Transplantation

Study ID: NCT03192007
Start Date: 2027-07-01
End Date: 2028-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

140

Intervention / Treatment

Magnetic Resonance Imaging

Sponsor

University of Minnesota

Source: clinicaltrials.gov

Share:
Add to list

Mirabegron in Patients With Age-Related Macular Degeneration

Study ID: NCT07305298
Start Date: 2026-04-01
End Date: 2026-12-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

312

Intervention / Treatment

Mirabegron 50mg

Solifenacin 5mg

Sponsor

University of Naples

Source: clinicaltrials.gov

Share:
Add to list

Application of the Personalized N-of-1 Trial Design in Patients With Rheumatoid Arthritis

Study ID: NCT06016517
Start Date: 2026-03-15
End Date: 2028-12-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

18

Intervention / Treatment

Etanercept

Adalimumab

Upadacitinib

Tocilizumab

Sponsor

Tufts Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Usefulness and Feasibility of Ultrasound in Office Laryngology Procedures

Study ID: NCT06579989
Start Date: 2027-01
End Date: 2030-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Ultrasound for cough

Ultrasound for vocal fold atrophy or vocal fold paresis/paralysis

Ultrasound for dysphagia

Ultrasound for dysphonia

Sponsor

Weill Medical College of Cornell University

Source: clinicaltrials.gov

Share:
Add to list

Precision Care for Older Persons

Study ID: NCT07419789
Start Date: 2026-08-01
End Date: 2030-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

218

Intervention / Treatment

Advanced Person-Centered (APC) Smart Home Care Model

Sponsor

Chang Gung Memorial Hospital

Source: clinicaltrials.gov

Share:
Add to list

Prognostic Value of Transcranial Doppler Ultrasound in the Clinical Evolution of Patients With Acute Ischemic Stroke. The TRADE-AIS Study

Study ID: NCT07004790
Start Date: 2026-08-01
End Date: 2027-08-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Transcranial Doppler Ultrasound

Sponsor

Jose Ivan Rodriguez de Molina Serrano

Source: clinicaltrials.gov

Share:
Add to list

Pharmacokinetics of Antituberculosis Drugs in Breastfeeding Women

Study ID: NCT07069582
Start Date: 2026-04-01
End Date: 2026-10-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

60

Intervention / Treatment

Standard dose rifampicin

High dose rifampicin

Standard dose isoniazid

Standard dose levofloxacin

Standard dose rifapentine

Standard dose bedaquiline

Sponsor

McGill University Health Centre/Research Institute of the McGill University Health Centre

Source: clinicaltrials.gov

Share:
Add to list